Publications by authors named "V de Falco"

Wine production is one of the most important agricultural activities. The winemaking process generates a considerable volume of different residues characterized as by-products, such as pomace, seeds, stems, and skins. By-products are rich in polyphenols with antioxidant and antibacterial properties and may act as bacteriostatic or bactericidal agents against food-borne pathogens, improving food safety by enhancing antibiotic efficacy and reducing bacterial resistance.

View Article and Find Full Text PDF
Article Synopsis
  • - Axitinib, a drug used for advanced kidney cancer, is being tested for effectiveness against glioblastoma, a severe brain tumor, and shows improved results when combined with other treatments
  • - Research indicates that axitinib can lead to cellular senescence (aging) in both tumor and normal cells, but using the antioxidant N-Acetyl-L-Cysteine (NAC) may limit this effect in normal cells while preserving its anti-cancer properties
  • - The study reveals that NAC combined with axitinib enhances blood vessel health in brain tumors and protects against liver damage from axitinib, suggesting a potential for better treatment outcomes with reduced side effects
View Article and Find Full Text PDF

In most human tumors, the MAPK pathway is constitutively activated. Since p90RSK is downstream of MAPK, it is often hyperactive and capable of phosphorylating oncogenic substrates. We have previously shown that p90RSK phosphorylates MDM2 at S166, promoting p53 degradation in follicular thyroid carcinomas.

View Article and Find Full Text PDF

Elite controllers (ECs), a unique group of people with HIV (PWH), exhibit remarkable control of viral replication in the absence of antiretroviral therapy. In this study, we comprehensively characterized the NK cell repertoire in ECs after long-term viral control. Phenotypic profiling of NK cells revealed profound differences compared with other PWH, but marked similarities to uninfected individuals, with a distinctive prevalence of NKG2C+CD57+ memory-like NK cells.

View Article and Find Full Text PDF

Human T-lymphotropic virus 1 produces a latent infection and disease with poor prognosis. Although its transmission during solid-organ transplant and development of the disease has been described, it is not clear whether antiretroviral treatment could prevent it. We report the first kidney transplant of a donor with human T-lymphotropic virus positivity to a negative recipient who was under antiretroviral treatment without evidence of transmission.

View Article and Find Full Text PDF